| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of duodenum dissemination after surgery for colon cancer which immunotherapy was significantly effective
|
Machida, Tomohiko
|
|
|
29 |
S7 |
p. vii79
|
artikel
|
| 2 |
A case of pulmonary embolism and non bacterial thrombotic endocarditis after chemotherapy to pancreatic cancer
|
Shinohara, Yudai
|
|
|
29 |
S7 |
p. vii80
|
artikel
|
| 3 |
A case of recurrent pancreatic cancer diagnosed with skull metastasis in dysphagia / diplopia and treated
|
Iijima, Kazutaka
|
|
|
29 |
S7 |
p. vii80
|
artikel
|
| 4 |
A case of the AFP production cancer of the PIVKA-II, HER2 positive stomach which had difficulty in Pathologic Diagnosis
|
Shimono, Chigusa
|
|
|
29 |
S7 |
p. vii79
|
artikel
|
| 5 |
A comprehensive gene mutation profiling of liquid biopsy samples from patients with gynecologic cancer by using CAPP-seq
|
Iwahashi, Naoyuki
|
|
|
29 |
S7 |
p. vii53
|
artikel
|
| 6 |
Acute kidney injury associated with dabrafenib and trametinib treatment for metastatic melanoma: a case report
|
Ikesue, Hiroaki
|
|
|
29 |
S7 |
p. vii83
|
artikel
|
| 7 |
Adapalene gel 0.1% vs. placebo as prophylaxis for anti-EGFR-induced acne-like rash: a randomized comparative evaluation
|
Fujishima, Yoshimi
|
|
|
29 |
S7 |
p. vii65
|
artikel
|
| 8 |
A detailed evaluation method of CD4 + T cell subsets
|
Tsuda, Banri
|
|
|
29 |
S7 |
p. vii70
|
artikel
|
| 9 |
Adult rhabdomyosarcoma with bleeding tendency as an initial clinical manifestation
|
Goto, Hideko
|
|
|
29 |
S7 |
p. vii71
|
artikel
|
| 10 |
Advances in therapeutic approaches for multiple myeloma
|
Kizaki, Masahiro
|
|
|
29 |
S7 |
p. vii29
|
artikel
|
| 11 |
AI technology for precision medicine: current status and future perspectives
|
Okuno, Yasushi
|
|
|
29 |
S7 |
p. vii1
|
artikel
|
| 12 |
All oncologists are geriatric oncologists
|
Brain, Etienne G.C.
|
|
|
29 |
S7 |
p. vii6
|
artikel
|
| 13 |
A multicenter, open-label, uncontrolled study of ONO-7643/anamorelin in cachexia patients with gastrointestinal cancer
|
Furuse, Junji
|
|
|
29 |
S7 |
p. vii50
|
artikel
|
| 14 |
Analyses of CD204+ macrophages in allogeneic stem cell transplantation for malignant lymphoma in non-remission
|
Kawajiri, Akihisa
|
|
|
29 |
S7 |
p. vii63
|
artikel
|
| 15 |
Analysis of clinical presentation and prognosis of diffuse large B-cell lymphoma in patients over 80 years of age
|
Lee, Shin
|
|
|
29 |
S7 |
p. vii63
|
artikel
|
| 16 |
An effect of comprehensive geriatric assessment in elderly patients with non-Hodgkin lymphoma treated with chemotherapy
|
Nakamura, Nobuhiko
|
|
|
29 |
S7 |
p. vii61
|
artikel
|
| 17 |
A new colorectal cancer marker, TMEM180 and its preclinical antibody development
|
Matsumura, Yasuhiro
|
|
|
29 |
S7 |
p. vii9
|
artikel
|
| 18 |
An open-label phase 1 trial of lenvatinib plus pembrolizumab in patients with advanced selected solid tumors
|
Kitano, Shigehisa
|
|
|
29 |
S7 |
p. vii81
|
artikel
|
| 19 |
A novel therapeutic approach for glioblastoma: blocking CD47-SIRPα axis alone or combined with autophagy inhibitor
|
Chen, Wei
|
|
|
29 |
S7 |
p. vii73
|
artikel
|
| 20 |
An overview of cancer-associated thrombosis (CAT)
|
Shiga, Taro
|
|
|
29 |
S7 |
p. vii8
|
artikel
|
| 21 |
Anti-angiogenesis inhibitor combined with immunotherapy for metastatic gastric or gastroesophageal adenocarcinoma
|
Muro, Kei
|
|
|
29 |
S7 |
p. vii28
|
artikel
|
| 22 |
Antiemetic efficacy and safety of olanzapine for chemotherapy-induced nausea and vomiting in patients with breast cancer
|
Murakami, Akari
|
|
|
29 |
S7 |
p. vii53
|
artikel
|
| 23 |
An update on the diagnosis and management of gastroenteropancreatic neuroendocrine tumors
|
Ito, Tetsuhide
|
|
|
29 |
S7 |
p. vii42
|
artikel
|
| 24 |
A phase 1b study of S-1 combined with trastuzumab emtansine (T-DM1) for HER2 positive metastatic breast cancer
|
Kojima, Yasuyuki
|
|
|
29 |
S7 |
p. vii78
|
artikel
|
| 25 |
A phase III trial of Cape/5-FU+Bmab followed by CapeOX/mFOLFOX6+Bmab vs. CapeOX/mFOLFOX6+Bmab in mCRC: C-Cubed(C3) study
|
Ishibashi, Keiichiro
|
|
|
29 |
S7 |
p. vii68
|
artikel
|
| 26 |
A phase II study of first-line low-dose afatinib in patients with EGFR mutated non-small-cell lung cancer (KTORG1402)
|
Okuno, Takehiro
|
|
|
29 |
S7 |
p. vii58
|
artikel
|
| 27 |
A phase II study of low-dose erlotinib in frail patients with EGFR-mutant non-small cell lung cancer: TORG1425
|
Bessho, Akihiro
|
|
|
29 |
S7 |
p. vii59
|
artikel
|
| 28 |
A phase II study of nab-PTX in combination with RAM in patients with pre-treated AGC: results of final analysis
|
Takashima, Atsuo
|
|
|
29 |
S7 |
p. vii67
|
artikel
|
| 29 |
A phase II study of nivolumab: a multicenter, open-label, single arm study in malignant pleural mesothelioma (MERIT)
|
Aoe, Keisuke
|
|
|
29 |
S7 |
p. vii52
|
artikel
|
| 30 |
A phase II study on the efficacy of Nivolumab in Japanese patients with cancer of unknown primary (CUP) (NivoCUP)
|
Tanizaki, Junko
|
|
|
29 |
S7 |
p. vii57
|
artikel
|
| 31 |
A phase I trial of BI 754091, a programmed death receptor 1 (PD-1) inhibitor, in patients with advanced solid tumors
|
Johnson, Melissa
|
|
|
29 |
S7 |
p. vii60
|
artikel
|
| 32 |
A potential predictive model for oxaliplatin plus 5-fluorouracil response in advanced colorectal cancer patients
|
Gu, Junjie
|
|
|
29 |
S7 |
p. vii74
|
artikel
|
| 33 |
A prognostic model integrating clinical data and gene signatures in phase III neoadjuvant trial CALGB 40601 (Alliance)
|
Tanioka, Maki
|
|
|
29 |
S7 |
p. vii50
|
artikel
|
| 34 |
A qualitative study of user perspectives on using medication administration information system in oncology wards
|
Lin, Wan-Shiuan
|
|
|
29 |
S7 |
p. vii62
|
artikel
|
| 35 |
A randomized phase II study to assess trastuzumab beyond progression in HER2-positive advanced gastric cancer: WJOG7112G
|
Esaki, Taito
|
|
|
29 |
S7 |
p. vii55
|
artikel
|
| 36 |
A retrospective study of the survival and subsequent treatment after EGFR-TKIs for NSCLC at Chiba University Hospital
|
Iwasawa, Shunichiro
|
|
|
29 |
S7 |
p. vii80
|
artikel
|
| 37 |
A retrospective study to compare TAS-102 with TAS-102+BV in advanced colorectal cancer refractory to standard therapy
|
Makiyama, Akitaka
|
|
|
29 |
S7 |
p. vii75
|
artikel
|
| 38 |
A review of S-1 and S-1+Platinum for late-stage elderly patients with metastatic gastric cancer as a first-line regimen
|
Kobayashi, Kazuma
|
|
|
29 |
S7 |
p. vii74
|
artikel
|
| 39 |
Association between lymphocyte-monocyte ratio and sarcopenia in Indonesian breast cancer patients
|
Putri, Helenia
|
|
|
29 |
S7 |
p. vii78
|
artikel
|
| 40 |
ATOM trial: a randomized phase II study of mFOLFOX6+Bmab vs. mFOLFOX6+Cmab for not-optimary resectable KRAS wt mCRC
|
Muro, Kei
|
|
|
29 |
S7 |
p. vii51
|
artikel
|
| 41 |
Attempts at assisted reproductive medical intervention in breast cancer patients who desire fertility preservation
|
Goda, Noriko
|
|
|
29 |
S7 |
p. vii57
|
artikel
|
| 42 |
Autophagy inhibition improves CD47-blocking immunotherapy in laryngeal squamous cell carcinoma
|
Luan, Jingyun
|
|
|
29 |
S7 |
p. vii72
|
artikel
|
| 43 |
Awareness towards cervical cancer in undergraduate students
|
Setiawati Tanzil, Sheila
|
|
|
29 |
S7 |
p. vii69
|
artikel
|
| 44 |
A 10-year population-based study of the differences between NECs and carcinomas of the esophagus
|
Cai, Wen
|
|
|
29 |
S7 |
p. vii62
|
artikel
|
| 45 |
Bevacizumab combined with a taxane and a platinum agent as first-line treatment for advanced-stage ovarian cancer
|
Kato, Kazuyoshi
|
|
|
29 |
S7 |
p. vii30
|
artikel
|
| 46 |
Cancer immunotherapy with autologous γδ T cells
|
Kakimi, Kazuhiro
|
|
|
29 |
S7 |
p. vii19
|
artikel
|
| 47 |
Cancer-oriented comprehensive nursing care service in Korea: outcomes and issues
|
Kim, Hyojin
|
|
|
29 |
S7 |
p. vii70-vii71
|
artikel
|
| 48 |
Cancer survivorship: optimizing quality care, health, function and well-being
|
Feuerstein, Michael
|
|
|
29 |
S7 |
p. vii33
|
artikel
|
| 49 |
CARF regulates EMT through Wnt/b-catenin signaling: its clinical relevance & potential as a therapeutic cancer target
|
Wadhwa, Renu
|
|
|
29 |
S7 |
p. vii52
|
artikel
|
| 50 |
Central venous port infection during the early postoperative period after placement in patients with solid cancers
|
Tanaka, Hiroshi
|
|
|
29 |
S7 |
p. vii83
|
artikel
|
| 51 |
Characterization of URST1 as a biomarker and therapeutic target for lung cancer and oral cancer
|
Takano, Atsushi
|
|
|
29 |
S7 |
p. vii54
|
artikel
|
| 52 |
Chemotherapy for advanced hepatocellular carcinoma, Japanese perspective
|
Ikeda, Masafumi
|
|
|
29 |
S7 |
p. vii10
|
artikel
|
| 53 |
Chinese herbal formula "JinQi" used as maintenace treatment for breast cancer
|
Li, Yanchu
|
|
|
29 |
S7 |
p. vii66
|
artikel
|
| 54 |
Circular RNA profile identifies circOSBPL10 is unregulated and as a proliferative factor in gastric cancer
|
Chen, Jie
|
|
|
29 |
S7 |
p. vii55
|
artikel
|
| 55 |
Circulating tumour cells and circulating stem-like cancer cells were prognostic factors in metastatic breast cancer
|
Yeh, Ting-Shiuan
|
|
|
29 |
S7 |
p. vii66
|
artikel
|
| 56 |
Clarification of mechanisms of acquired resistance for afatinib using plasma samples
|
Nakamura, Tomomi
|
|
|
29 |
S7 |
p. vii56
|
artikel
|
| 57 |
Clinical burden of prognostic nutrition index in patients with rectal cancer who receive preoperative chemoradiotherapy
|
Okugawa, Yoshinaga
|
|
|
29 |
S7 |
p. vii74
|
artikel
|
| 58 |
Clinical courses of peritoneal and pleural malignant mesothelioma, a single-center experience
|
Asayama, Masako
|
|
|
29 |
S7 |
p. vii83
|
artikel
|
| 59 |
Clinical features of skeletal metastases originated from advanced pancreatic cancer
|
Ushida, Yuta
|
|
|
29 |
S7 |
p. vii75
|
artikel
|
| 60 |
Clinical guideline for gastrointestinal cancers in Korea with focusing on metastatic gastric cancer
|
Ryu, Minhee
|
|
|
29 |
S7 |
p. vii16
|
artikel
|
| 61 |
Clinical investigation of enzalutamide for nonmetastatic castration-resistant prostate cancer (M0CRPC)
|
Mukouyama, Hideki
|
|
|
29 |
S7 |
p. vii76
|
artikel
|
| 62 |
Colorectal cancer survival in Japanese-American population
|
Al-Husseini, Muneer J.
|
|
|
29 |
S7 |
p. vii64
|
artikel
|
| 63 |
Combined radiation therapy and immunotherapy including blockade of immune checkpoint
|
Akimoto, Tetsuo
|
|
|
29 |
S7 |
p. vii13
|
artikel
|
| 64 |
Communication skills training for nurses
|
Fukui, Sakiko
|
|
|
29 |
S7 |
p. vii31
|
artikel
|
| 65 |
Communication skills training for oncologists
|
Fujimori, Maiko
|
|
|
29 |
S7 |
p. vii31
|
artikel
|
| 66 |
Comparison of administration status and adverse events in each cancer type using ramucirumab
|
Sakata, Yukio
|
|
|
29 |
S7 |
p. vii77
|
artikel
|
| 67 |
Comprehensive screening of target molecules by next-generation sequencing in patients with malignant tumors
|
Tamura, Kenji
|
|
|
29 |
S7 |
p. vii26
|
artikel
|
| 68 |
Comprehensive treatment decision support of more than 1,000 patients by the medical device Molecular Health Guide®
|
Kaduthanam, Sajo
|
|
|
29 |
S7 |
p. vii71-vii72
|
artikel
|
| 69 |
Confident BRCA1/2 variant classification: using ACMG and public data for systematic molecular profiling
|
Schmidt-Edelkraut, Udo
|
|
|
29 |
S7 |
p. vii71
|
artikel
|
| 70 |
Correlation between SARC-F and IADL score in breast cancer patients: a preliminary study
|
Wijovi, Felix
|
|
|
29 |
S7 |
p. vii82
|
artikel
|
| 71 |
Coverings avoid frostbites and do not reduce efficacy of cryotherapy for prevention of chemotherapy-induced neuropathy
|
Hanai, Akiko
|
|
|
29 |
S7 |
p. vii65
|
artikel
|
| 72 |
Current positioning of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in Japan
|
Yamashita, Tatsuya
|
|
|
29 |
S7 |
p. vii10
|
artikel
|
| 73 |
Current progress of peri-operative therapy for esophageal cancer
|
Kato, Ken
|
|
|
29 |
S7 |
p. vii21
|
artikel
|
| 74 |
Current situation and perspectives of Medical Oncology in Singapore
|
Choo, Su Pin
|
|
|
29 |
S7 |
p. vii5
|
artikel
|
| 75 |
Current situation,issues and prospects of "AYA get-together": a get-together for adolescents and young adults with cancer
|
Hirayama, Takatoshi
|
|
|
29 |
S7 |
p. vii71
|
artikel
|
| 76 |
Current situation of CRC treatment in China
|
Li, Jin
|
|
|
29 |
S7 |
p. vii5
|
artikel
|
| 77 |
Current Situation of Precision Medicine in Lung Cancer
|
Tanaka, Kentaro
|
|
|
29 |
S7 |
p. vii3
|
artikel
|
| 78 |
Current standard and future perspectives in the post-operative treatment of triple negative breast cancer
|
Hara, Fumikata
|
|
|
29 |
S7 |
p. vii38
|
artikel
|
| 79 |
Current status and perspective of treatment for adolescents and young adults with lymphoma
|
Sekimizu, Masahiro
|
|
|
29 |
S7 |
p. vii23
|
artikel
|
| 80 |
Current status of cancer medicine in Taiwan
|
Yen, Yun
|
|
|
29 |
S7 |
p. vii5
|
artikel
|
| 81 |
Current topics of immune checkpoint inhibitors in perioperative and locally advanced non-small cell lung cancer
|
Horinouchi, Hidehito
|
|
|
29 |
S7 |
p. vii15
|
artikel
|
| 82 |
Detection of mismatch repair protein deficient colorectal cancer and hereditary cancer syndrome
|
Akagi, Kiwamu
|
|
|
29 |
S7 |
p. vii12
|
artikel
|
| 83 |
Development of oncogene panel for detecting predictive and prognostic factors of metastatic colorectal cancer
|
Uetake, Hiroyuki
|
|
|
29 |
S7 |
p. vii12
|
artikel
|
| 84 |
Development of targeted therapy for advanced non-small cell lung cancer with rare driver oncogenes as RET or MET
|
Yoh, Kiyotaka
|
|
|
29 |
S7 |
p. vii20
|
artikel
|
| 85 |
Diagnostic and therapeutic strategies for cancer-therapy cardiotoxicity
|
Ishida, Junichi
|
|
|
29 |
S7 |
p. vii8
|
artikel
|
| 86 |
DNA damage response(DDR) interventions in betel-nuts related head and squamous cell carcinoma(HNSCC) in Taiwan
|
Chen, Jo-Pai
|
|
|
29 |
S7 |
p. vii73
|
artikel
|
| 87 |
Docetaxel, cisplatin and fluorouracil as neoadjuvant chemotherapy for esophageal cancer with prophylactic pegfilgrastim
|
Maeda, Osamu
|
|
|
29 |
S7 |
p. vii67
|
artikel
|
| 88 |
Does a prior malignancy impact the survival of transitional cell carcinoma of the bladder?
|
Alkhayat, Mohamad A.
|
|
|
29 |
S7 |
p. vii56-vii57
|
artikel
|
| 89 |
Does clinical features, treatment, and prognosis of elderly hepatocellular carcinoma differ from those of young people?
|
Sugimoto, Rie
|
|
|
29 |
S7 |
p. vii37
|
artikel
|
| 90 |
Editorial board
|
|
|
|
29 |
S7 |
p. ii-iii
|
artikel
|
| 91 |
Effects of chemotherapy on body function and utilization on breast cancer patients in Indonesia: a preliminary study
|
Evangelista, Nadya N.
|
|
|
29 |
S7 |
p. vii82
|
artikel
|
| 92 |
Efficacy and safety of megestrol acetate plus zusanli(ST 36) point injection in the prevention of CINV
|
Ji, Shengwei
|
|
|
29 |
S7 |
p. vii82
|
artikel
|
| 93 |
Efficacy and safety of nivolumab for previously treated non-squamous cell carcinoma of the head and neck
|
Suzuki, Chiaki
|
|
|
29 |
S7 |
p. vii66
|
artikel
|
| 94 |
Efficacy and safety of nivolumab in patients with uterine cervical cancer, uterine corpus cancer, or soft-tissue sarcoma
|
Katsumata, Noriyuki
|
|
|
29 |
S7 |
p. vii60
|
artikel
|
| 95 |
Efforts of peer support activities by cancer survivors
|
Suzuki, Makiko
|
|
|
29 |
S7 |
p. vii33
|
artikel
|
| 96 |
EGFR-TKIs can overcome prognostic disadvantage of emergent SREs at the first visit in lung cancer patients
|
Kunimasa, Kei
|
|
|
29 |
S7 |
p. vii80
|
artikel
|
| 97 |
Enhancement of ALA-based photodynamic therapy efficacy in sex hormonal dependent cancer models: an in vitro study
|
Chu, Ellie S.M.
|
|
|
29 |
S7 |
p. vii81
|
artikel
|
| 98 |
ESMO guideline of esophago-gastric cancer
|
Lordick, Florian
|
|
|
29 |
S7 |
p. vii16
|
artikel
|
| 99 |
Evaluation of diarrhea as immune-related adverse event by colonoscopy
|
Arai, Makoto
|
|
|
29 |
S7 |
p. vii56
|
artikel
|
| 100 |
Exclusion of stage IV transitional cell carcinoma of the bladder with prior cancers from clinical trials. Is it valid?
|
Alkhayat, Mohamad A.
|
|
|
29 |
S7 |
p. vii76
|
artikel
|
| 101 |
Expression and significance of oncogenic miRNAs (21,17,10 A&B) with breast cancer stem cell in breast carcinoma patients
|
Dwivedi, Shailendra
|
|
|
29 |
S7 |
p. vii58
|
artikel
|
| 102 |
Expression of cancer stem cell CD44 in patients with chronic gastritis, pre-cancerous and gastric cancer in Thailand
|
Tongtawee, Taweesak
|
|
|
29 |
S7 |
p. vii79
|
artikel
|
| 103 |
Factors affect patients' outcome with malignant rhabdoid tumor: a long time retrospective study
|
Cai, Wen
|
|
|
29 |
S7 |
p. vii61
|
artikel
|
| 104 |
Factors which potentially impact on investigational sites initiation time of oncology clinical trials
|
Sano, Ayaka
|
|
|
29 |
S7 |
p. vii70
|
artikel
|
| 105 |
Febrile non-haemolytic transfusion reaction in thalassemia patients at Hasan Sadikin Hospital
|
Prihadi, Dinny G.
|
|
|
29 |
S7 |
p. vii68
|
artikel
|
| 106 |
FOLFIRINOX therapy for recurrent or unresectable pancreatic cancer
|
Tsujie, Masanori
|
|
|
29 |
S7 |
p. vii79
|
artikel
|
| 107 |
Future directions of soft tissue sarcoma
|
Naito, Yoichi
|
|
|
29 |
S7 |
p. vii34
|
artikel
|
| 108 |
Future perspectives of PARP inhibitors in Japan at 2018; challenges and opportunities
|
Matsumoto, Koji
|
|
|
29 |
S7 |
p. vii14
|
artikel
|
| 109 |
Future perspectives of precision medicine for NSCLC
|
Zhou, Caicun
|
|
|
29 |
S7 |
p. vii18
|
artikel
|
| 110 |
Gemcitabine, carboplatin, and dexamethasone as salvage chemotherapy for outpatients with relapsed or refractory lymphoma
|
Iino, Masaki
|
|
|
29 |
S7 |
p. vii76
|
artikel
|
| 111 |
Genomic medicine and hereditary cancer
|
Sugano, Kokichi
|
|
|
29 |
S7 |
p. vii40
|
artikel
|
| 112 |
Geriatric oncology in Japan
|
Nagashima, Fumio
|
|
|
29 |
S7 |
p. vii6
|
artikel
|
| 113 |
Geriatrics for geriatric oncology
|
Rostoft, Siri
|
|
|
29 |
S7 |
p. vii6
|
artikel
|
| 114 |
Germinoma : Histopathology and Imaging Characteristics of Rare Brain Tumors in Siloam Hospital
|
Putri, Helenia
|
|
|
29 |
S7 |
p. vii73
|
artikel
|
| 115 |
Global phase III trial of comparing mXELIRI+BV vs FOLFIRI+Bmab for 2nd line mCRC (AXEPT) Japanese population analysis
|
Kato, Takeshi
|
|
|
29 |
S7 |
p. vii51
|
artikel
|
| 116 |
Helicobacter pylori and gastric cancer “Thailand Enigma”
|
Pratoomchat, Boonjiraporn
|
|
|
29 |
S7 |
p. vii67
|
artikel
|
| 117 |
Heterogeneity of EGFR-mutant and PD-L1 high-expressing clones affects treatment efficacy of EGFR-TKI and PD-1 inhibitor
|
Kunimasa, Kei
|
|
|
29 |
S7 |
p. vii69
|
artikel
|
| 118 |
HGCSG 1403: phase I trial of oxaliplatin /irinotecan /S-1 (OX-IRIS) for unresectable pancreatic cancer
|
Kawamoto, Yasuyuki
|
|
|
29 |
S7 |
p. vii63
|
artikel
|
| 119 |
Histone demethylase KDM4C is a novel oncogene and prognostic biomarker for prostate cancer
|
Chuu, Chih-Pin
|
|
|
29 |
S7 |
p. vii54-vii55
|
artikel
|
| 120 |
How can psycho-oncology work together with oncology and palliative care?
|
Fujisawa, Daisuke
|
|
|
29 |
S7 |
p. vii7
|
artikel
|
| 121 |
How should we exploit TAS-102?
|
Tsukuda, Hiroshi
|
|
|
29 |
S7 |
p. vii75
|
artikel
|
| 122 |
Hyperprogression during nivolumab (Nivo) or irinotecan (IRI) as salvage-line in patients with metastatic gastric cancer
|
Sugimoto, Naotoshi
|
|
|
29 |
S7 |
p. vii55-vii56
|
artikel
|
| 123 |
Identifying differentially expressed genes and key pathways in giant cell tumor of bone by transcriptome profiling
|
Tsui, Joseph C.
|
|
|
29 |
S7 |
p. vii77
|
artikel
|
| 124 |
Immune checkpoint inhibitors and neuromuscular adverse events
|
Suzuki, Shigeaki
|
|
|
29 |
S7 |
p. vii35
|
artikel
|
| 125 |
Immuno-oncology biomarker study in a large cohort of LC-SCRUM-Japan: LC-SCRUM-IBIS
|
Kunimasa, Kei
|
|
|
29 |
S7 |
p. vii52
|
artikel
|
| 126 |
Immunotherapies of nasopharyngeal carcinoma
|
Ma, Brigette
|
|
|
29 |
S7 |
p. vii13
|
artikel
|
| 127 |
Immunotherapy for advanced gastric cancer
|
Kang, Yoon-Koo
|
|
|
29 |
S7 |
p. vii9
|
artikel
|
| 128 |
Immunotherapy for renal cell carcinoma: the differences from melanoma
|
Miura, Yuji
|
|
|
29 |
S7 |
p. vii24
|
artikel
|
| 129 |
Impact of relative dose intensity of R-CHOP on outcomes of patients with advanced follicular lymphoma
|
Konishi, Tatsuya
|
|
|
29 |
S7 |
p. vii60
|
artikel
|
| 130 |
Impact of S-1 on advanced pancreatic cancer in Taiwan
|
Kuo, Yung-Chia
|
|
|
29 |
S7 |
p. vii79
|
artikel
|
| 131 |
Importance to clarify germline hMLH1 K618A missense mutation for clinical surveillance and genetic counseling
|
Liu, Tao
|
|
|
29 |
S7 |
p. vii64
|
artikel
|
| 132 |
Initiatives for business classification at Tohoku University Hospital ethics review committee secretariat
|
Takano, Tadao
|
|
|
29 |
S7 |
p. vii70
|
artikel
|
| 133 |
Intelligent treatment decision support combining variant interpretation and phenotype analytics can transform healthcare
|
Soldatos, Theodoros
|
|
|
29 |
S7 |
p. vii84
|
artikel
|
| 134 |
Interim PET-CT-adapted treatment for malignant lymphoma
|
Izutsu, Koji
|
|
|
29 |
S7 |
p. vii17
|
artikel
|
| 135 |
Introduction
|
Nakanishi, Yoichi
|
|
|
29 |
S7 |
p. vii
|
artikel
|
| 136 |
Investigator initiated clinical trial of cancer vaccine OCV-C01 in advanced and recurrent biliary tract cancer
|
Murahashi, Mutsunori
|
|
|
29 |
S7 |
p. vii60
|
artikel
|
| 137 |
Investigator initiated clinical trials in Korea; current issues and perspectives focusing in breast cancer trial
|
Sohn, Joohyuk
|
|
|
29 |
S7 |
p. vii4
|
artikel
|
| 138 |
Issues and perspectives of drug development from Asia; a view from Singapore in breast cancer trials
|
Yap, Yoon-Sim
|
|
|
29 |
S7 |
p. vii4
|
artikel
|
| 139 |
Issue to be solved in the near future to determine optimal sequential endocrine therapy in metastatic breast cancer
|
Yamamoto, Yutaka
|
|
|
29 |
S7 |
p. vii11
|
artikel
|
| 140 |
KEYNOTE-061: pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer
|
Shitara, Kohei
|
|
|
29 |
S7 |
p. vii49
|
artikel
|
| 141 |
Key roles of immune-check inhibitors for first- and second line treatment for advanced NSCLC
|
Perol, Maurice
|
|
|
29 |
S7 |
p. vii15
|
artikel
|
| 142 |
Knowledge of prevention and risk factor of cervical cancer in undergraduated students in Tangerang
|
Setiawati Tanzil, Sheila
|
|
|
29 |
S7 |
p. vii68-vii69
|
artikel
|
| 143 |
Large-scale nationwide genomic screening system for small cell lung cancer in Japan (LC-SCRUM-Japan)
|
Okamoto, Norio
|
|
|
29 |
S7 |
p. vii54
|
artikel
|
| 144 |
Latest advances in palliative cancer care: delirium, dyspnea and decision making
|
Hui, David
|
|
|
29 |
S7 |
p. vii32
|
artikel
|
| 145 |
Liver cirrhosis associated with paclitaxel and bevacizumab combination therapy in a metastatic breast cancer patient
|
Nio, Kenta
|
|
|
29 |
S7 |
p. vii78
|
artikel
|
| 146 |
Malignant melanoma in paranasal sinus without expression of S-100 protein: a case report and review in literature
|
Takada, Midori
|
|
|
29 |
S7 |
p. vii69
|
artikel
|
| 147 |
Management of Immune-Related Adverse Events
|
Fujisaka, Yasuhito
|
|
|
29 |
S7 |
p. vii45
|
artikel
|
| 148 |
Managements of oncologic emergency occurred in patients with advanced cancer
|
Takahashi, Masanobu
|
|
|
29 |
S7 |
p. vii44
|
artikel
|
| 149 |
Medical and dental cooperation using VPN with IPsec in the hospital without dentists
|
Ina, Kenji
|
|
|
29 |
S7 |
p. vii84
|
artikel
|
| 150 |
Medical oncology group of Australia: taking a leading role in medical oncology education, patient care & research
|
Karapetis, Christos S.
|
|
|
29 |
S7 |
p. vii5
|
artikel
|
| 151 |
Medical oncology in multidisciplinary approach for head and neck cancer
|
Yokota, Tomoya
|
|
|
29 |
S7 |
p. vii22
|
artikel
|
| 152 |
Molecular subtype and treatment strategy
|
Stintzing, Sebastian
|
|
|
29 |
S7 |
p. vii12
|
artikel
|
| 153 |
Molecular targeted therapies for HCC: recent advances and future challenges
|
Finn, Richard S.
|
|
|
29 |
S7 |
p. vii10
|
artikel
|
| 154 |
Molecular targeting agents and cardiovascular adverse events
|
Kimura, Shinya
|
|
|
29 |
S7 |
p. vii8
|
artikel
|
| 155 |
Multidiciplinary treatment for head and neck cancer -surgical oncologist's point of view-
|
Nakashima, Torahiko
|
|
|
29 |
S7 |
p. vii22
|
artikel
|
| 156 |
Multidisciplinary lung cancer tumor board connecting eight hospitals via the high-security communication line
|
Takeda, Takayuki
|
|
|
29 |
S7 |
p. vii53
|
artikel
|
| 157 |
Multidisciplinary Treatment for Pancreatic Cancer: Conversion Surgery for Initially Unresectable Pancreatic Cancer
|
Motoi, Fuyuhiko
|
|
|
29 |
S7 |
p. vii39
|
artikel
|
| 158 |
Nationwide cancer genome screening project utilizing circulating tumor DNA analysis for advanced gastrointestinal cancer
|
Nakamura, Yoshiaki
|
|
|
29 |
S7 |
p. vii27
|
artikel
|
| 159 |
Neoadjuvant and adjuvant immunotherapy in patients undergoing head and neck cancer surgery
|
Okami, Kenji
|
|
|
29 |
S7 |
p. vii13
|
artikel
|
| 160 |
Neoadjuvant chemoradiotherapy for locally advanced rectal cancer. A study at Ho Chi Minh City Oncology Hospital
|
Nguyen, Thanh H.V.
|
|
|
29 |
S7 |
p. vii67
|
artikel
|
| 161 |
Neoadjuvant doxorubicin and cyclophosphamide followed by paclitaxel dose dense in stage III breast cancer
|
Tai Dang, Voc
|
|
|
29 |
S7 |
p. vii73
|
artikel
|
| 162 |
New cancer supportive care system based on the outpatient chemotherapy unit in immune-checkpoint inhibitor era
|
Takahashi, Hidenori
|
|
|
29 |
S7 |
p. vii77
|
artikel
|
| 163 |
New development strategies of immunotherapy agents for colorectal cancer
|
Tabernero, Josep
|
|
|
29 |
S7 |
p. vii9
|
artikel
|
| 164 |
New therapeutic strategies for mantle cell lymphoma
|
Yamamoto, Kazuhito
|
|
|
29 |
S7 |
p. vii17
|
artikel
|
| 165 |
Next-generation therapy for multiple myeloma
|
Kizaki, Masahiro
|
|
|
29 |
S7 |
p. vii43
|
artikel
|
| 166 |
NLR and its relative change early during nivolumab treatment could be useful to predict outcome in advanced NSCLC
|
Nakamura, Morio
|
|
|
29 |
S7 |
p. vii80
|
artikel
|
| 167 |
Oncological and obstetric management of women diagnosed with cancer during pregnancy: overcoming the challenge
|
Sonoda, Kenzo
|
|
|
29 |
S7 |
p. vii25
|
artikel
|
| 168 |
Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer who have poor performance status
|
Kimura, Madoka
|
|
|
29 |
S7 |
p. vii59
|
artikel
|
| 169 |
Outcome of progestin therapy in patients with endometrial cancer recurrence
|
Yoriki, Kaori
|
|
|
29 |
S7 |
p. vii69
|
artikel
|
| 170 |
Outcome of systemic treatment in elderly compared to younger patients with metastatic colorectal cancer
|
Kashiwada, Tomomi
|
|
|
29 |
S7 |
p. vii82
|
artikel
|
| 171 |
Outcomes of primary and secondary breast diffuse large B-cell lymphoma in rituximab-era
|
Nishimura, Noriko
|
|
|
29 |
S7 |
p. vii59
|
artikel
|
| 172 |
Outpatient chemotherapy for patients with unresectable or metastatic bone sarcomas
|
Urakawa, Hiroshi
|
|
|
29 |
S7 |
p. vii61-vii62
|
artikel
|
| 173 |
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer ; A JSMO - ESMO initiative
|
Yoshino, Takayuki
|
|
|
29 |
S7 |
p. vii16
|
artikel
|
| 174 |
Pan-Asian adapted ESMO guidelines for the management of patients with metastatic oesophageal and gastric cancer
|
Muro, Kei
|
|
|
29 |
S7 |
p. vii16
|
artikel
|
| 175 |
Patient-reported outcomes in oncology
|
Yamaguchi, Takuhiro
|
|
|
29 |
S7 |
p. vii2
|
artikel
|
| 176 |
Patients expectation for drug discovery development targeting rare cancers
|
Majima, Yoshiyuki
|
|
|
29 |
S7 |
p. vii36
|
artikel
|
| 177 |
PD-L2 expression as a predictive biomarker for the response to anti-PD-1 drugs in non-small cell lung cancer patients
|
Takamori, Shinkichi
|
|
|
29 |
S7 |
p. vii81
|
artikel
|
| 178 |
Phase II study of osimertinib in patients with plasma EGFR T790M positive advanced lung cancer (WJOG8815L/LPS)
|
Takahama, Takayuki
|
|
|
29 |
S7 |
p. vii50
|
artikel
|
| 179 |
Phase II trial of neoadjuvant S-1 and concurrent radiotherapy for borderline resectable pancreatic cancer (JASPAC05)
|
Ohno, Izumi
|
|
|
29 |
S7 |
p. vii62-vii63
|
artikel
|
| 180 |
Phase I study of once-weekly high-dose carfilzomib and dexamethasone (Cd) in Japanese patients with RRMM
|
Chou, Takaaki
|
|
|
29 |
S7 |
p. vii71
|
artikel
|
| 181 |
Phase I study of spartalizumab (PDR001), an anti-PD1 mAb, in Japanese patients with advanced malignancies
|
Ando, Yuichi
|
|
|
29 |
S7 |
p. vii61
|
artikel
|
| 182 |
Phase 1 study on safety and PK of rovalpituzumab tesirine (Rova-T) in Japanese patients with advanced, recurrent SCLC
|
Tanaka, Kentaro
|
|
|
29 |
S7 |
p. vii57
|
artikel
|
| 183 |
Photodynamic therapy induced apoptosis and autophagy in 2D and 3D nasopharyngeal carcinoma cell models
|
Wu, Ricky W.K.
|
|
|
29 |
S7 |
p. vii83
|
artikel
|
| 184 |
Potential research and clinical utility of liquid biopsy with CAPP seq
|
Takahama, Takayuki
|
|
|
29 |
S7 |
p. vii27
|
artikel
|
| 185 |
Practical issues and future perspectives on early phase development in Asia- competition, collaboration and harmonization
|
Shimizu, Toshio
|
|
|
29 |
S7 |
p. vii4
|
artikel
|
| 186 |
Precision medicine for gastrointestinal cancers
|
Shitara, Kohei
|
|
|
29 |
S7 |
p. vii3
|
artikel
|
| 187 |
Predicting the risk of peripheral neuropathy by the combination of four serum microRNAs
|
Narita, Shoko
|
|
|
29 |
S7 |
p. vii57-vii58
|
artikel
|
| 188 |
Predictive factor of hyperprogressive disease during nivolumab in patients with advanced gastric cancer
|
Sasaki, Akinori
|
|
|
29 |
S7 |
p. vii56
|
artikel
|
| 189 |
Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼
|
Ogawa, Chikara
|
|
|
29 |
S7 |
p. vii52
|
artikel
|
| 190 |
Predictors and risk factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
|
Tan, Yinuo
|
|
|
29 |
S7 |
p. vii64-vii65
|
artikel
|
| 191 |
Preliminary result of p1/2 study of ramucirumab plus nivolumab in patients with pretreated advanced gastric carcinoma
|
Esaki, Taito
|
|
|
29 |
S7 |
p. vii55
|
artikel
|
| 192 |
Present status and problem of robotic preparation for anticancer infusion drugs in Mie University Hospital
|
Iwamoto, Takuya
|
|
|
29 |
S7 |
p. vii48
|
artikel
|
| 193 |
Prevalence, genetic features, and anti-cancer drug sensitivity of NUT midline carcinoma
|
Okumura, Shunsuke
|
|
|
29 |
S7 |
p. vii62
|
artikel
|
| 194 |
Primary tumor location for angiogenesis inhibitor effectiveness in mCRC
|
Kuboki, Yasutoshi
|
|
|
29 |
S7 |
p. vii28
|
artikel
|
| 195 |
Prognostic value of subtype changes after neoadjuvant chemotherapy in primary breast cancer
|
Matsumoto, Akiko
|
|
|
29 |
S7 |
p. vii58
|
artikel
|
| 196 |
Promotion and challenges of Development for Orphan Drugs in Japan
|
Nakamura, Harumasa
|
|
|
29 |
S7 |
p. vii41
|
artikel
|
| 197 |
Prospects of community based integrated care system in the terminal care of lung cancer after medical fees revision 2018
|
Kato, Kan
|
|
|
29 |
S7 |
p. vii53
|
artikel
|
| 198 |
Real-world delivery rate to third-line chemotherapy in patients with advanced gastric cancer
|
Ueno, Masayuki
|
|
|
29 |
S7 |
p. vii73
|
artikel
|
| 199 |
Retrospective analysis of the clinical outcome of hypocellular acute myeloid leukemia in a single institution
|
Suyama, Takuya
|
|
|
29 |
S7 |
p. vii68
|
artikel
|
| 200 |
Retrospective study to evaluate treatment outcomes of Pleural Mesothelioma treated in a tertiary care centre from India
|
Chanana, Raajit
|
|
|
29 |
S7 |
p. vii75-vii76
|
artikel
|
| 201 |
Risk of sarcopenia as the side effect of chemotherapy among breast cancer patients: preliminary study
|
Agatha, Cindy M.
|
|
|
29 |
S7 |
p. vii82
|
artikel
|
| 202 |
Role of radiotherapy for multidisciplinary treatment of head and neck cancer
|
Kodaira, Takeshi
|
|
|
29 |
S7 |
p. vii22
|
artikel
|
| 203 |
Roles & opportunities of oncology phase 1 trials in Asia: providing ethnic sensitivity evaluation for Asians/Caucasians
|
Lin, Chia-Chi
|
|
|
29 |
S7 |
p. vii4
|
artikel
|
| 204 |
Safety and effectiveness of pembrolizumab monotherapy in NSCLC: Interim analysis of Japan postmarketing surveillance
|
Kato, Terufumi
|
|
|
29 |
S7 |
p. vii51
|
artikel
|
| 205 |
Scalp cooling by Cool Cap can help to avoid alopecia of adverse event by standard chemotherapy for breast cancer
|
Yamashita, Koji
|
|
|
29 |
S7 |
p. vii66
|
artikel
|
| 206 |
Scientific evidence on secondhand smoke exposure
|
Katanoda, Kota
|
|
|
29 |
S7 |
p. vii47
|
artikel
|
| 207 |
Screening colonoscopy for colorectal tumors in H. pylori-related chronic gastritis with MDM2 SNP309 GG homozygous
|
Champamoon, Supakorn
|
|
|
29 |
S7 |
p. vii64
|
artikel
|
| 208 |
Seamless environment of antineoplastic drugs preparation combining robotic system and isolators
|
Kuroda, Junko
|
|
|
29 |
S7 |
p. vii48
|
artikel
|
| 209 |
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
|
Miya, Toshimichi
|
|
|
29 |
S7 |
p. vii54
|
artikel
|
| 210 |
Severe mucositis induced by hepatic arterial infusion therapy: a case report
|
Kumazawa, Satomi
|
|
|
29 |
S7 |
p. vii68
|
artikel
|
| 211 |
Successful treatment of large transformed mycosis fungoides with gemcitabine monotherapy
|
Asai, Hiroaki
|
|
|
29 |
S7 |
p. vii77
|
artikel
|
| 212 |
Survey of end-of-life medical care of lung cancer
|
Sakamoto, Tomohiro
|
|
|
29 |
S7 |
p. vii78
|
artikel
|
| 213 |
Survival of right versus left colorectal cancer in Japanese-American population
|
Rachid, Ahmad
|
|
|
29 |
S7 |
p. vii64
|
artikel
|
| 214 |
Survival of transitional cell carcinoma of the bladder for Japanese patients residing in the United States
|
Kunbaz, Ahmad
|
|
|
29 |
S7 |
p. vii56
|
artikel
|
| 215 |
Systemic therapy for advanced melanoma: current knowledge and future directions
|
Okuyama, Ryuhei
|
|
|
29 |
S7 |
p. vii24
|
artikel
|
| 216 |
Table of Contents
|
|
|
|
29 |
S7 |
p. iv-v
|
artikel
|
| 217 |
TAS-102 in metastatic colorectal cancer (mCRC) - predictive and prognostic factors in a European patient population
|
Obermannova, Radka
|
|
|
29 |
S7 |
p. vii74
|
artikel
|
| 218 |
The bone health of Japanese patients with breast cancer
|
Ono, Hisako
|
|
|
29 |
S7 |
p. vii81
|
artikel
|
| 219 |
The development of TNBC treatment through overcoming heterogeneity
|
Masuda, Hiroko
|
|
|
29 |
S7 |
p. vii38
|
artikel
|
| 220 |
The difficulty in establishing clinical evidence of extremely-rare hematological malignancies
|
Ishitsuka, Kenji
|
|
|
29 |
S7 |
p. vii41
|
artikel
|
| 221 |
The educational system about geriatric oncology in Japan
|
Tsubata, Yukari
|
|
|
29 |
S7 |
p. vii6
|
artikel
|
| 222 |
The effectiveness of cancer chemotherapy among elderly patients: a retrospective study in Miyagi Cancer Center
|
Murakawa, Yasuko
|
|
|
29 |
S7 |
p. vii61
|
artikel
|
| 223 |
The efficacy of subsequent chemotherapy after programmed cell death 1 inhibitor treatment in non-small cell lung cancer
|
Shiozawa, Toshihiro
|
|
|
29 |
S7 |
p. vii70
|
artikel
|
| 224 |
The functional role of NGFR in regulating chemosensitivity in nasopharyngeal carcinoma
|
Gao, Wei
|
|
|
29 |
S7 |
p. vii72
|
artikel
|
| 225 |
The function of CD271 in the development of stem-like cell phenotype in nasopharyngeal carcinoma
|
Zhang, Minjuan
|
|
|
29 |
S7 |
p. vii72
|
artikel
|
| 226 |
The future application of artificial intelligence to pathology diagnosis
|
Fukuoka, Junya
|
|
|
29 |
S7 |
p. vii1
|
artikel
|
| 227 |
The impact of 15 years of precision medicine innovation on the treatment of lung cancer
|
Johnson, Bruce E.
|
|
|
29 |
S7 |
p. vii3
|
artikel
|
| 228 |
The Nationwide Cancer Genome Screening Project in Japan SCRUM-Japan GI-SCREEN
|
Kawazoe, Akihito
|
|
|
29 |
S7 |
p. vii26
|
artikel
|
| 229 |
The optimal treatment strategy in primary central nervous system lymphoma, 32 cases in our hospital
|
Takeuchi, Yuki
|
|
|
29 |
S7 |
p. vii59
|
artikel
|
| 230 |
The overall survival in patients with medically inoperable stage I NSCLC that recurred after radical radiotherapy
|
Kashiwabara, Kosuke
|
|
|
29 |
S7 |
p. vii75
|
artikel
|
| 231 |
The PEAK1-PPP1R12B axis inhibits the development of colorectal cancer via regulating Grb2/PI3K/Akt signaling
|
Ding, Chenbo
|
|
|
29 |
S7 |
p. vii63
|
artikel
|
| 232 |
The phase II study of nab-paclitaxel for relapsed NSCLC (NLCTG1302)
|
Tanaka, Tomohiro
|
|
|
29 |
S7 |
p. vii54
|
artikel
|
| 233 |
The possible association of gastric adenocarcinoma with lung and colorectal cancers
|
Qaddoora, Umniyah Sh.
|
|
|
29 |
S7 |
p. vii76
|
artikel
|
| 234 |
Therapeutic strategies for metastatic triple negative breast cancer
|
Takano, Toshimi
|
|
|
29 |
S7 |
p. vii38
|
artikel
|
| 235 |
The relationship between serum level of copper and ceruloplasmin and pathologic and clinical characteristics in EBC
|
Fan, Jing
|
|
|
29 |
S7 |
p. vii58
|
artikel
|
| 236 |
The results of questionnaire survey on the usefulness of the communication tools in palliative care
|
Tomomatsu, Yuko
|
|
|
29 |
S7 |
p. vii83-vii84
|
artikel
|
| 237 |
The role of polo-like kinase1 inhibition in Small Cell Lung Carcinomas
|
Noro, Rintaro
|
|
|
29 |
S7 |
p. vii54
|
artikel
|
| 238 |
The role of the regional cancer care critical paths to establish a regional medical network
|
Sasaki, Jiichiro
|
|
|
29 |
S7 |
p. vii46
|
artikel
|
| 239 |
The safety and efficacy of FOLFIRI combined Ramucirumab for metastatic colorectal cancer as 2nd line
|
Osawa, Hiroshi
|
|
|
29 |
S7 |
p. vii74-vii75
|
artikel
|
| 240 |
The tumorigenic functions of NADPH oxidase 5 (NOX5) in oral tongue squamous cell carcinoma
|
Wong, Thian-Sze
|
|
|
29 |
S7 |
p. vii72
|
artikel
|
| 241 |
Three cases of venous thromboembolism in advanced cancer patients
|
Komine, Keigo
|
|
|
29 |
S7 |
p. vii8
|
artikel
|
| 242 |
To live and work with lung cancer : coping strategies of a stage 4 patient
|
Kono, Satoko
|
|
|
29 |
S7 |
p. vii78
|
artikel
|
| 243 |
Vasohibin-2 is a novel molecular target for the treatment of gastrointestinal cancers
|
Sato, Yasufumi
|
|
|
29 |
S7 |
p. vii28
|
artikel
|
| 244 |
What patients expect from upcoming pancreatic cancer therapy
|
Majima, Yoshiyuki
|
|
|
29 |
S7 |
p. vii39
|
artikel
|
Tijdschrift beschrijving